BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34700279)

  • 21. Genetic landscape of external auditory canal squamous cell carcinoma.
    Sato K; Komune N; Hongo T; Koike K; Niida A; Uchi R; Noda T; Kogo R; Matsumoto N; Yamamoto H; Masuda M; Oda Y; Mimori K; Nakagawa T
    Cancer Sci; 2020 Aug; 111(8):3010-3019. PubMed ID: 32500594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. cN+pN0 disease does not portend a less favorable prognosis compared with cN0pN0 in patients with resected oral cavity squamous cell carcinoma.
    Lin CY; Lee LY; Cheng NM; Lee SR; Tsai CY; Hsueh C; Fan KH; Wang HM; Hsieh CH; Ng SH; Yeh CH; Lin CH; Tsao CK; Fang TJ; Huang SF; Lee LA; Kang CJ; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Liao CT
    Cancer Med; 2021 Oct; 10(20):6947-6958. PubMed ID: 34558224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk analysis of malignant potential of oral verrucous hyperplasia: A follow-up study of 269 patients and copy number variation analysis.
    Wu MH; Luo JD; Wang WC; Chang TH; Hwang WL; Lee KH; Liu SY; Yang JW; Chiou CT; Chang CH; Chiang WF
    Head Neck; 2018 May; 40(5):1046-1056. PubMed ID: 29377391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Genetic Biomarkers Based on Oncogenic Signaling Pathways for Outcome Prediction in Patients with Oral Cavity Squamous Cell Carcinoma.
    Fan WL; Yang LY; Hsieh JC; Lin TC; Lu MJ; Liao CT
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34070941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extranodal extension in resected oral cavity squamous cell carcinoma: more to it than meets the eye.
    Agarwal JP; Kane S; Ghosh-Laskar S; Pilar A; Manik V; Oza N; Wagle P; Gupta T; Budrukkar A; Murthy V; Swain M
    Laryngoscope; 2019 May; 129(5):1130-1136. PubMed ID: 30421434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What has the National Cancer Database taught us about oral cavity squamous cell carcinoma?
    Graillon N; Iocca O; Carey RM; Benjamin K; Cannady SB; Hartner L; Newman JG; Rajasekaran K; Brant JA; Shanti RM
    Int J Oral Maxillofac Surg; 2022 Jan; 51(1):10-17. PubMed ID: 33840565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing reliability of intra-tumor heterogeneity estimates from single sample whole exome sequencing data.
    Abécassis J; Hamy AS; Laurent C; Sadacca B; Bonsang-Kitzis H; Reyal F; Vert JP
    PLoS One; 2019; 14(11):e0224143. PubMed ID: 31697689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical, pathological and molecular determinants in squamous cell carcinoma of the oral cavity.
    Al-Swiahb JN; Chen CH; Chuang HC; Fang FM; Tasi HT; Chien CY
    Future Oncol; 2010 May; 6(5):837-50. PubMed ID: 20465394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of Copy Number Variations in Oral Cavity Squamous Cell Carcinoma Reveals a Novel Role for MLLT3 in Cell Invasiveness.
    Wang CI; Kao HK; Chen TW; Huang Y; Cheng HW; Yi JS; Hung SY; Wu CS; Lee YS; Chang KP
    Oncologist; 2019 Dec; 24(12):e1388-e1400. PubMed ID: 31273053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide CRISPR screens of oral squamous cell carcinoma reveal fitness genes in the Hippo pathway.
    Chai AWY; Yee PS; Price S; Yee SM; Lee HM; Tiong VK; Gonçalves E; Behan FM; Bateson J; Gilbert J; Tan AC; McDermott U; Garnett MJ; Cheong SC
    Elife; 2020 Sep; 9():. PubMed ID: 32990596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole-exome sequencing of transforming oral lichen planus reveals mutations in DNA damage repair and apoptosis pathway genes.
    Xie F; Gleue CA; Deschaine M; Dasari S; Lau JS; Sartori-Valinotti JC; Meves A; Lehman JS
    J Oral Pathol Med; 2022 Apr; 51(4):395-404. PubMed ID: 35146808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Independent Predictors of Prognosis Based on Oral Cavity Squamous Cell Carcinoma Surgical Margins.
    Buchakjian MR; Ginader T; Tasche KK; Pagedar NA; Smith BJ; Sperry SM
    Otolaryngol Head Neck Surg; 2018 Oct; 159(4):675-682. PubMed ID: 29737907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated APOBEC mutational signatures implicate chronic injury in etiology of an aggressive head-and-neck squamous cell carcinoma: a case report.
    Patel J; den Breems NY; Tuluc M; Johnson J; Curry JM; South AP; Cho RJ
    J Med Case Rep; 2021 Apr; 15(1):252. PubMed ID: 33926553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies.
    Fadlullah MZ; Chiang IK; Dionne KR; Yee PS; Gan CP; Sam KK; Tiong KH; Ng AK; Martin D; Lim KP; Kallarakkal TG; Mustafa WM; Lau SH; Abraham MT; Zain RB; Rahman ZA; Molinolo A; Patel V; Gutkind JS; Tan AC; Cheong SC
    Oncotarget; 2016 May; 7(19):27802-18. PubMed ID: 27050151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymph node ratio-dependent prognosis stratification and postoperative radiotherapy utilization in T1-2N1 oral cavity carcinoma.
    Wang J; Liu Y; Shayan G; Ma Y; Yi J
    Radiother Oncol; 2022 Jul; 172():83-90. PubMed ID: 35568286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinoma.
    Essers PBM; van der Heijden M; Vossen D; de Roest RH; Leemans CR; Brakenhoff RH; van den Brekel MWM; Bartelink H; Verheij M; Vens C
    Int J Cancer; 2020 Sep; 147(6):1732-1739. PubMed ID: 32167160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcomes in oral cavity squamous cell carcinoma with adjuvant and salvage radiotherapy after surgery.
    Katsoulakis E; Leeman JE; Lok BH; Shi W; Zhang Z; Tsai JC; McBride SM; Sherman EJ; Cohen M; Wong R; Ganly I; Lee NY; Riaz N
    Laryngoscope; 2018 Nov; 128(11):2539-2545. PubMed ID: 29637571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
    Guo H; Li C; Su X; Huang X
    Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
    [No Abstract]   [Full Text] [Related]  

  • 39. Precision Adjuvant Therapy Based on Detailed Pathologic Risk Factors for Resected Oral Cavity Squamous Cell Carcinoma: Long-Term Outcome Comparison of CGMH and NCCN Guidelines.
    Lin CY; Fan KH; Lee LY; Hsueh C; Yang LY; Ng SH; Wang HM; Hsieh CH; Lin CH; Tsao CK; Kang CJ; Fang TJ; Lee LA; Huang SF; Chang KP; Yen TC; Tay ZY; Wen YW; Lee SR; Liao CT
    Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):916-925. PubMed ID: 31499138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and Outcomes of Patients With Oral Cavity Squamous Cell Carcinoma and Fourth Primary Tumors: A Long-term Follow-up Study in a Betel Quid Chewing Endemic Area.
    Adel M; Liao CT; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Ng SH; Lin CH; Tsao CK; Huang SF; Kang CJ; Fang KH; Wang YC; Chang KP; Fang TJ; Yang LY; Yen TC
    Medicine (Baltimore); 2016 Mar; 95(12):e2950. PubMed ID: 27015170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.